Search Results - "Mincheff, M."

Refine Results
  1. 1
  2. 2
  3. 3

    Changes in Donor Leukocytes during Blood Storage. Implications on Post- Transfusion Immunomodulation and Transfusion-Associated GVHD by Mincheff, M.

    Published in Vox sanguinis (01-06-1998)
    “…Freshly drawn peripheral blood granulocytes, monocytes and NK cells express Fas‐L following activation. Fully functional soluble Fas‐L (sFas‐L) is released and…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Immunosurveillance and immunoediting--can the immune response be made more "immunodemocratic"? by Mincheff, M

    Published in Journal of B.U. ON. (01-09-2009)
    “…Increasing evidence has demonstrated that the immune system is able to mount responses against tumors and that these responses can be enhanced using a number…”
    Get more information
    Journal Article
  5. 5

    Immune responses against PSMA after gene-based vaccination for immunotherapy - A: results from immunizations in animals by Mincheff, M, Zoubak, S, Makogonenko, Y

    Published in Cancer gene therapy (01-04-2006)
    “…Two plasmid DNA vaccines, encoding either products that are retained in the cytosol and degraded in the proteasome (tVacs; hPSMAt), or secreted proteins…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Biochemical Nature and Mapping of PSMA Epitopes Recognized by Human Antibodies Induced after Immunization with Gene-based Vaccines by TODOROVA, K, ZOUBAK, S, MINCHEFF, M, KYURKCHIEV, S

    Published in Anticancer research (01-11-2005)
    “…Background: A possible new target for immunotherapy is the prostate-specific membrane antigen (PSMA). The aim of the present study was to define potential PSMA…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Blood transfusion and immunomodulation: a possible mechanism by Mincheff, M S, Meryman, H T, Kapoor, V, Alsop, P, Wötzel, M

    Published in Vox sanguinis (01-01-1993)
    “…To induce an immunogenic response in vivo, an antigen-presenting (stimulator) cell must present both antigen-specific (class II MHC) and an accessory signal to…”
    Get more information
    Journal Article
  10. 10

    Mechanisms of alloimmunization and immunosuppression by blood transfusions in an inbred rodent model by Mincheff, M S, Getsov, S I, Meryman, H T

    Published in Transplantation (27-10-1995)
    “…During refrigerated storage leukocytes in donor blood progressively undergo apoptosis followed by secondary necrosis. Using an inbred rodent transfusion model,…”
    Get more information
    Journal Article
  11. 11

    Blood transfusion, blood storage and immunomodulation by Mincheff, M S, Meryman, H T

    Published in Immunological investigations (01-01-1995)
    “…Allogeneic blood transfusion is the most frequent allotransplantation procedure performed on a routine basis with no prior HLA-typing. Roughly 50% of the…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Fas and Fas Ligand Expression on Human Peripheral Blood Leukocytes by Mincheff, Milcho, Loukinov, Dmitri, Zoubak, Serguei, Hammett, Michael, Meryman, Harold

    Published in Vox sanguinis (1998)
    “…Objectives: Study of Fas and Fas ligand (Fas-L) expression, as well as sFas-L release, by fresh human peripheral blood leukocytes. Methods: Flow cytometry,…”
    Get full text
    Journal Article
  14. 14

    Costimulatory signals necessary for induction of T cell proliferation by Mincheff, M S, Meryman, H T

    Published in Transplantation (01-04-1990)
    “…Two separate signals are required for induction of T cell proliferation. In an attempt to identify them we used polyclonal T cell activation with Con A, which…”
    Get more information
    Journal Article
  15. 15

    PF779 VIABILITY OF HEMATOPOETIC STEM CELLS FOLLOWING STORAGE AT −80OC WITH 5% DIMETHYLSULFOXIDE AND HEMATOLOGIC RECOVERY IN TRANSPLANTED MYELOMA PATIENTS by Tonev, I., Simeonov, S., Mitkov, I., Ilieva, M., Petrov, Y., Ganeva, P., Arnaudov, G., Spassov, B., Mincheff, M.

    Published in HemaSphere (01-06-2019)
    “…Background: Dimethylsulfoxide (DMSO) is a major intracellular cryoprotectant, used for cryopreservation of stem cells. It is toxic to both cells and patients…”
    Get full text
    Journal Article
  16. 16

    PB2365 CELL DOSE AND HEMATOLOGIC RECOVERY AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA by Tonev, I., Simeonov, S., Mitkov, I., Ilieva, M., Petrov, Y., Ganeva, P., Arnaudov, G., Spassov, B., Mincheff, M.

    Published in HemaSphere (01-06-2019)
    “…Background: The relation between the dose of the infused hematopoietic stem cells and the time of hematologic recovery after autologous transplantation has…”
    Get full text
    Journal Article
  17. 17

    Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial by Mincheff, M, Tchakarov, S, Zoubak, S, Loukinov, D, Botev, C, Altankova, I, Georgiev, G, Petrov, S, Meryman, H T

    Published in European urology (01-08-2000)
    “…Animal studies have indicated that the use of syngeneic dendritic cells that have been transfected ex vivo with DNA for tumor-specific antigen results in tumor…”
    Get more information
    Journal Article
  18. 18

    Tularemia outbreak, Bulgaria, 1997-2005 by Kantardjiev, Todor, Ivanov, Ivan, Velinov, Tzvetan, Padeshki, Plamen, Popov, Boris, Nenova, Roumiana, Mincheff, Milcho

    Published in Emerging infectious diseases (01-04-2006)
    “…The 1997-2005 tularemia outbreak in Bulgaria affected 285 people. Ten strains were isolated from humans, a tick, a hare, and water. Amplified fragment length…”
    Get full text
    Journal Article
  19. 19

    Induction of primary mixed leukocyte reactions with ultraviolet B or chemically modified stimulator cells by Mincheff, M S, Meryman, H T

    Published in Transplantation (01-12-1989)
    “…Treatment of stimulator cells with 0.1% paraformaldehyde for 60 sec or ultraviolet-B (UV-B) irradiation (1000 J/m2) eliminates their ability to elicit T cell…”
    Get more information
    Journal Article
  20. 20